Elanco Net Receivables vs Accounts Payable Analysis
ELAN Stock | USD 17.14 0.35 2.08% |
Elanco Animal financial indicator trend analysis is much more than just examining Elanco Animal Health latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Elanco Animal Health is a good investment. Please check the relationship between Elanco Animal Net Receivables and its Accounts Payable accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Elanco Animal Health. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation.
Net Receivables vs Accounts Payable
Net Receivables vs Accounts Payable Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Elanco Animal Health Net Receivables account and Accounts Payable. At this time, the significance of the direction appears to have very strong relationship.
The correlation between Elanco Animal's Net Receivables and Accounts Payable is 0.83. Overlapping area represents the amount of variation of Net Receivables that can explain the historical movement of Accounts Payable in the same time period over historical financial statements of Elanco Animal Health, assuming nothing else is changed. The correlation between historical values of Elanco Animal's Net Receivables and Accounts Payable is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Receivables of Elanco Animal Health are associated (or correlated) with its Accounts Payable. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Accounts Payable has no effect on the direction of Net Receivables i.e., Elanco Animal's Net Receivables and Accounts Payable go up and down completely randomly.
Correlation Coefficient | 0.83 |
Relationship Direction | Positive |
Relationship Strength | Strong |
Net Receivables
Accounts Payable
An accounting item on the balance sheet that represents Elanco Animal obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Elanco Animal Health are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.Most indicators from Elanco Animal's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Elanco Animal Health current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Elanco Animal Health. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. Elanco Animal reported last year Issuance Of Capital Stock of (100,000). As of the 29th of May 2024, Enterprise Value Over EBITDA is likely to grow to 23.56, while Tax Provision is likely to drop (13.7 M).
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 2.6B | 2.5B | 2.5B | 2.0B | Total Revenue | 4.8B | 4.4B | 4.4B | 3.9B |
Elanco Animal fundamental ratios Correlations
Click cells to compare fundamentals
Elanco Animal Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Elanco Animal fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Common Stock Shares Outstanding | 370.3M | 441.4M | 487.2M | 488.3M | 492.3M | 447.6M | |
Total Assets | 9.0B | 17.7B | 16.5B | 15.5B | 14.4B | 13.6B | |
Other Current Liab | 455.4M | 872.2M | 746M | 924M | 409M | 631.8M | |
Total Current Liabilities | 818.5M | 2.1B | 1.6B | 1.7B | 1.2B | 1.3B | |
Total Stockholder Equity | 5.5B | 8.5B | 7.5B | 7.3B | 6.2B | 7.6B | |
Other Liab | 228.2M | 1.3B | 1.2B | 941M | 1.1B | 780.6M | |
Net Tangible Assets | 74.5M | (4.1B) | (4.3B) | (3.5B) | (3.2B) | (3.0B) | |
Property Plant And Equipment Net | 955.3M | 1.3B | 1.1B | 999M | 1.0B | 1.1B | |
Net Debt | 2.0B | 5.6B | 5.7B | 5.5B | 5.4B | 3.5B | |
Retained Earnings | 84.3M | (477.2M) | (949M) | (1.1B) | (2.3B) | (2.2B) | |
Accounts Payable | 222.6M | 501M | 418M | 390M | 270M | 335.3M | |
Cash | 334M | 494.7M | 638M | 345M | 352M | 442.8M | |
Non Current Assets Total | 6.6B | 14.3B | 13.2B | 12.2B | 11.0B | 10.5B | |
Non Currrent Assets Other | 185M | 347.8M | 387M | 378M | 341M | 300.8M | |
Other Assets | 78.9M | 127.3M | 183M | 193M | 173.7M | 123.4M | |
Cash And Short Term Investments | 334M | 494.7M | 638M | 345M | 352M | 442.8M | |
Net Receivables | 889.9M | 1.1B | 1.0B | 1.0B | 1.0B | 955.4M | |
Good Will | 3.0B | 6.2B | 6.2B | 6.0B | 5.1B | 4.8B | |
Liabilities And Stockholders Equity | 9.0B | 17.7B | 16.5B | 15.5B | 14.4B | 13.6B | |
Non Current Liabilities Total | 2.6B | 7.1B | 7.3B | 6.5B | 6.9B | 4.7B | |
Inventory | 1.1B | 1.6B | 1.4B | 1.5B | 1.7B | 1.4B | |
Other Current Assets | 87.4M | 256.3M | 237M | 394M | 310M | 236.1M | |
Other Stockholder Equity | 5.6B | 8.7B | 8.7B | 8.7B | 8.8B | 8.4B | |
Total Liab | 3.4B | 9.2B | 8.9B | 8.2B | 8.1B | 6.0B | |
Property Plant And Equipment Gross | 955.3M | 1.3B | 2.1B | 1.7B | 1.8B | 1.4B | |
Total Current Assets | 2.4B | 3.4B | 3.3B | 3.3B | 3.4B | 3.1B | |
Accumulated Other Comprehensive Income | (173.7M) | 303M | (209M) | (392M) | (266M) | (279.3M) | |
Non Current Liabilities Other | 106.6M | 322.1M | 261M | 229M | 411M | 232.2M | |
Intangible Assets | 2.5B | 6.4B | 5.6B | 4.8B | 4.5B | 4.3B | |
Property Plant Equipment | 1.0B | 1.3B | 1.2B | 999M | 1.1B | 1.1B | |
Net Invested Capital | 7.9B | 14.6B | 13.9B | 13.1B | 12.0B | 12.1B | |
Net Working Capital | 1.6B | 1.3B | 1.6B | 1.6B | 2.2B | 1.8B | |
Short Long Term Debt Total | 2.4B | 6.1B | 6.3B | 5.8B | 5.8B | 5.3B | |
Current Deferred Revenue | 116M | 148.6M | 185M | 524M | 602.6M | 632.7M | |
Long Term Debt | 2.3B | 5.6B | 6.0B | 5.4B | 5.7B | 5.1B | |
Retained Earnings Total Equity | 84.3M | (477.2M) | (949M) | (1.1B) | (951.3M) | (903.7M) | |
Capital Surpluse | 5.6B | 8.7B | 8.7B | 8.7B | 10.0B | 8.2B | |
Short Long Term Debt | 24.5M | 554.5M | 294M | 388M | 38M | 36.1M | |
Short Term Debt | 24.5M | 554.5M | 294M | 388M | 38M | 36.1M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Elanco Animal Health. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. Note that the Elanco Animal Health information on this page should be used as a complementary analysis to other Elanco Animal's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Complementary Tools for Elanco Stock analysis
When running Elanco Animal's price analysis, check to measure Elanco Animal's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Elanco Animal is operating at the current time. Most of Elanco Animal's value examination focuses on studying past and present price action to predict the probability of Elanco Animal's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Elanco Animal's price. Additionally, you may evaluate how the addition of Elanco Animal to your portfolios can decrease your overall portfolio volatility.
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
CEOs Directory Screen CEOs from public companies around the world | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |
Is Elanco Animal's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Elanco Animal. If investors know Elanco will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Elanco Animal listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.71) | Earnings Share (2.70) | Revenue Per Share 8.857 | Quarterly Revenue Growth (0.04) | Return On Assets 0.0103 |
The market value of Elanco Animal Health is measured differently than its book value, which is the value of Elanco that is recorded on the company's balance sheet. Investors also form their own opinion of Elanco Animal's value that differs from its market value or its book value, called intrinsic value, which is Elanco Animal's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Elanco Animal's market value can be influenced by many factors that don't directly affect Elanco Animal's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Elanco Animal's value and its price as these two are different measures arrived at by different means. Investors typically determine if Elanco Animal is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Elanco Animal's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.